柳娟  

特聘教授、博士生导师

E-mail:liujuan@bucm.edu.cn

个人简介

柳娟博士于2011毕业于华中科技大学同济医学院药学院国家生命科学与技术基地班(生物药学)获学士学位,2016年毕业于中国科学院大学国家纳米科学中心和法国艾克斯-马赛大学,双博士学位。2016-2019年于军事医学研究院从事博士后研究。2016-2019年于军事医学研究院从事博士后研究。2019年-2026年4月就职于清华大学北京清华长庚医院肝胆胰中心。2026年5月人才引进加入北京中医药大学。现任未来医学学院副院长,类器官与器官芯片方向负责人。

柳娟博士长期从事生物材料与类器官组织工程、新药开发与评价方面研究,主持承担国家自然科学基金(3项)、国家重点研发专项课题、北京市自然科学基金等项目14项,作为科研骨干参与国科金重大项目、重点项目、重大研究计划等20余项。以第一/通讯作者在Nature BME.、Sci. Adv.、Signal Transduct Target Ther.、Sci Bull、Adv Sci.、Biomaterials等期刊发表论文70多篇,总被引8800多次,单篇最高被引超1200次,5篇入选ESI高被引,获Biomaterials杰出论文奖及Wiley威立中国高贡献作者奖(4次);主笔制定首部肝脏类器官应用团体标准,获授权国家发明专利11项,并荣获北京市自然科学一等奖及中国科技产业化促进会标准创新一等奖等。曾荣获法国政府最高奖学金埃菲尔奖学金;入选北京市优秀青年人才、北京市科协青年人才托举工程、北京市青苗人才计划、中国科协智库青年人才计划等,此外担任北京市理化分析测试学会青年委员理事会副主任委员、北京智慧医疗技术创新联盟智慧药学专业委员会委员和北京慢性病防治与健康教育研究会成果转化专业委员会委员等;清华大学医师科学家发展中心学术工作组成员、北京理工大学前沿交叉科学研究院生物与医药硕士专业学位校外导师、国家纳米科学中心研究生产业实践导师;Cell proliferation、Organoid research、Exploration、BMEMat 、Interdisciplinary Medicine、iLiver等十余本期刊编委/青年编委。

研究领域

主要聚焦类器官-器官芯片与中医药的医工交叉前沿研究,面向重大复杂疾病机制解析与创新药物研发的关键瓶颈问题,构建融合类器官仿生建模、器官芯片微工程、功能生物材料、多维多组学解析与人工智能计算的跨尺度医工交叉研究体系。主要研究方向包括:

    类器官与器官芯片疾病仿生模型构建及病理机制解析:整合人源干细胞工程、原代组织重构与功能生物材料技术,构建肝脏、消化系统、代谢及炎症肿瘤相关高保真类器官与多器官耦联器官芯片仿生系统;聚焦病理微环境重塑、细胞代谢重编程与异质性细胞互作,解码复杂疾病发生演进的分子调控逻辑,并结合活体动物体系完成多层次功能验证。

    基于类器官-器官芯片的中药及药食同源活性物质评价体系研究:以工程化类器官与器官芯片为体外仿生评价载体,建立面向中药活性成分、复方及药食同源物质的高精度药效-毒性评估技术范式;解析活性分子对病理代谢、炎症微环境及组织稳态的调控机理,推动中医药研究由传统成分表征向仿生功能评价、分子机制解析的范式跃迁。

    类器官系统多维组学解析与人工智能药物挖掘:针对慢病及衰老类器官开展单细胞转录组、空间多组学等多模态数据的深度挖掘与跨组学整合,重构疾病分子调控网络,识别潜在药物靶点与疗效响应标志物;融合机器学习与深度学习算法,开发面向类器官表型定量解析的智能分析策略,支撑疾病机制破译与先导候选药物的智能化筛选。

代表性成果

    1.Ji, F.#; Li, H.#; Wang, Q.#; Zhang, J.; Xiao, Y.; Li, H.; Liu, H.; Long, T.; Wu, B.; Chen, H.; Xia, H.; Liu, X.; Xu, C.; Gao, Y.; Tang, B.;* Liu, J.;* Yang, S.;* Dong, J.*, Spatial Multi-Omics Identifies a NOTCH3-Mediated Capillary–mCAF Crosstalk Driving Immune Exclusion in Hepatocellular Carcinoma. iMeta 2026, 5(2): e70117.

    2.Huang, Y.#; Wang, Q.#; Long, T.; Han, L.;* Wei, Y.;* Liu, J.* From Bioinks to Living Matter: Bioprinting Enters the "Pure Cell" Era. Science Bulletin 2026, in press.

    3.Liu, J.;*# Wang, Q.;# Chen, H.;# Yin, W.; Diao, J.; Ma, W.; Su, Y.; Le, Y.; Jin, B.; Dong, J.* Wang, Y.* Construction of Region-Specific Liver Organoids and Fabrication of Hierarchical Functional Liver Lobules for Liver Disease Modeling and Drug Evaluation. Science Bulletin 2025. Doi: 10.1016/j.scib.2025.07.021

    4.Wang, Q.;# Liu, J.;#* Yang, M.; Zhou, J.; Li, Y.; Zheng, J.; Jia, H.; Yue, S.; Le, Y.; Su, Y.; Ma, W.; An, N.; Wang, Y.;* Dong, J.* Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma. Signal Transduction and Targeted Therapy 2025, 10, 244.

    5.Liu, J.; Hanson, A.; Yin, W.; Wu, Q.; Wauthier, E.; Diao, J.; Dinh, T.; Macdonald, J.; Li, R.; Terajima, M.; Yamauchi, M.; Chen, Z.; Sethupathy, P.; Dong, J.; Reid, L.; Wang, Y.* Decellularized liver scaffolds for constructing drug-metabolically functional ex vivo human liver models. Bioactive Materials. 2025, 43, 162.

    6.Xin, W.; Cai, H.; Cui, X.; Han, L.;* Zhang, K.; Xue, X.; Song, Y.; Liu, J.;* Li, Z.* Empowering Flexible Electronics with Piezoelectric Nanogenerators: Breakthroughs from Energy Harvesting to Intelligent Sensing. Advanced Science 2025. 10.1002/advs.202519604

    7.Zheng, J.;# Li, X.;# Zhu, J.;# Liu, C.;# Song, X.; Wang, B.; Deng, Y.; Feng, Y.; Wang, Q.; Liu, J.;* Dong, H.;* Liang. XJ.;* Huang, Y.* Engineered Immune-driven Theranostics for Clinical Cardiology. Military Medical Research 2025.

    8.Liu, J.; Feng, Y.; Ge, J.;* Huang, Y.* Beyond the Needle: How MOF Nanocarriers Are Rewriting the Rules of Oral Protein Delivery. Matter 2025, 8, 102333.

    9.Wang, Q.; Long, T.; Tang, P.; Xu, C.; Wang, L.;* Liu, J.* Metabolic Reprogramming in Cholangiocarcinoma Cancer Stem Cells: Emerging Therapeutic Paradigms. Cancer Letter 2025. 622, 217714.

    10.Zhang, K.; Han, L.;* Cai, HQ.; Xue, XY.; Song, YF.; Xin, WL.; Wang, YZ.;* Liu, P.;* Liu, J.* Toward Personalized Healthcare: Advances in Two-Dimensional Nanomaterial-Based Flexible Electrochemical Sensors for Physiological Monitoring. BMEMat 2025. DOI: 10.1002/bmm2.70047

    11.Zhang, L.; Duan, X.; Shi, Q.; Yao, X.; Chen, Q.; Wan, J.; Wang, F.; Ni, C.; Li, Y.; Wang, M.; Sheng,Y.; Zheng, W.; Liu, J.;* Ji, T,;* Qin, Z.* Dual-functional Nanovesicles Simultaneously Inhibit Stromal Fibrosis and Angiogenesis to Suppress Cholangiocarcinoma Progression. Journal of Nanobiotechnology 2025. 10.1186/s12951-025-03833-w .

    12.Hu, Y.; Du, G.; Li, C.; Wang, R.; Liu, J.;* Wang, Y.;* Dong, J.* EGFR-mediated crosstalk between vascular endothelial cells and hepatocytes promotes Piezo1-dependent liver regeneration. Genes & Diseases 2025, 12, 101321.

    13.Jia, H.;# Liu, J.; # Fang, T.; Zhou, Z.; Li, R.; Yin, W.; Qian, Y.; Wang, Q.; Zhou, W.; Liu, C.; Sun, D.; Chen, X.; Ouyang, Z.; Dong, J.; Wang, Y.;* Yue, S.* The role of altered lipid composition and distribution in liver fibrosis revealed by multimodal nonlinear optical microscopy. Science Advances, 2023, 9, eabq2937.

    14.Liu, J.;#*Song, Q.;# Yin, W.; Li, C.; An, N.; Le, Y.; Wang, Q.; Feng, Y.; Hu, Y.; Wang, Y.* Bioactive Scaffolds for Tissue Engineering: A Review of Decellularized Extracellular Matrix Applications and Innovations. Exploration 2024.5, 20230078.

    15.Li, C.; An, N.; Song, Q.; Hu, Y.; Yin, W.; Wang, Q.; Le, Y.; Pan, W.; Yan, X.;* Wang, Y.;* Liu, J.* Enhancing Organoid Culture: Harnessing the Potential of Decellularized Extracellular Matrix Hydrogels for Mimicking Microenvironments. Journal of Biomedical Science. 2024, 31, 96.

    16.Liu, J.; Wang, Q.; Le, Y.; Hu, M.; Li, C.; An, N.; Song, Q.; Yin, W.; Ma, W.; Pan, M.; Feng, Y.; Wang, Y.;* Han, L.* Liu, J.* 3D-Bioprinting for Precision Microtissue Engineering: Advances, Applications, and Prospects. Advanced Healthcare Materials. 2024.202403781.

    17.Liu, J.; Li, R.; Zhang, T.; Xue, R.; Li, T.; Li, Z.; Zhuang, X.; Wang, Q.; Chen, Y.; Dong, J.; Zhang, Y.; Wang, Y. High-Content Imaging of Human Hepatic Spheroids for Researching the Mechanism of Duloxetine-induced Hepatotoxicity. Cell Death & Disease 2022, 13, 669.

    18.Li, R.;# Liu, J.;# Ma, J.; Sun, X.; Wang, Y.; Yan, J.; Yu, Q.; Diao, J.; Yang, C.; Reid, LM.; Wang, Y. Fibrinogen improves liver function via promoting cell aggregation and fibronectin assembly in hepatic spheroids. Biomaterials 2022, 280, 121266.

    20.Liu, J.; Chen, C.; Wei, T.; Gayet, O.; Loncle, C.; Borge L.; Dusetti, N.; Ma, X.; Marson, D.; Laurini, E.; Pricl, S.; Gu, Z.; Iovanna, J.; Peng, L.; Liang, XJ. Dendrimeric Nanosystem Consistently Circumvents Heterogeneous Drug Response and Resistance in Pancreatic Cancer. Exploration. 2021, 1, 1-14.

    21.Liu, J.; Wei, T.; Zhao, J.; Huang, Y.; Deng, H.; Kumar, A.; Wang, C.; Liang, Z.; Ma, X.; Liang, X. J., Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance. Biomaterials 2016, 91, 44-56.